Saša Čučnik Selected Research

Saša Čučnik Research Topics

Disease

11	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 11/2023 - 06/2011
7	Inflammation (Inflammations) 06/2023 - 01/2018
6	Thrombosis (Thrombus) 11/2023 - 06/2011
5	Alzheimer Disease (Alzheimer's Disease) 03/2024 - 01/2021
5	Rheumatoid Arthritis 01/2022 - 01/2016
4	COVID-19 11/2023 - 01/2020
4	Infections 12/2022 - 01/2018
4	Giant Cell Arteritis (Horton Disease) 06/2021 - 02/2019
4	Autoimmune Diseases (Autoimmune Disease) 01/2020 - 01/2013
4	Atherosclerosis 12/2019 - 10/2012
3	Systemic Scleroderma (Systemic Sclerosis) 07/2023 - 04/2021
3	Rheumatic Diseases (Rheumatism) 04/2021 - 12/2019
2	Cognitive Dysfunction 08/2023 - 01/2022
2	Interstitial Lung Diseases (Interstitial Lung Disease) 06/2023 - 02/2022
2	Dementia (Dementias) 01/2023 - 01/2021
2	Thrombophilia 01/2020 - 12/2011
2	Stroke (Strokes) 02/2019 - 10/2012
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2019 - 10/2012
1	Vasculitis (Vasculitides) 11/2023
1	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 10/2023
1	Fibrosis (Cirrhosis) 06/2023
1	Sarcoidosis (Schaumann Disease) 06/2023
1	Peritoneal Fibrosis 10/2022
1	Creutzfeldt-Jakob Syndrome (Creutzfeldt-Jakob Disease) 01/2022
1	Nervous System Diseases (Neurological Disorders) 01/2022
1	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 01/2022
1	Thromboembolism 04/2021
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 04/2021
1	Lupus Nephritis 04/2021
1	Cytokine Release Syndrome 01/2020
1	Acute Disease 02/2019
1	IgA Vasculitis (Purpura, Schoenlein Henoch) 02/2019
1	Diphtheria 01/2019
1	Tetanus 01/2019
1	Wounds and Injuries (Trauma) 01/2018
1	Mitochondrial Diseases (Mitochondrial Disease) 12/2017
1	Heart Failure 12/2017
1	Pregnancy Complications 01/2015
1	Venous Thrombosis (Deep-Vein Thrombosis) 01/2013
1	Coronary Artery Disease (Coronary Atherosclerosis) 10/2012
1	Peripheral Arterial Disease 10/2012

Drug/Important Bio-Agent (IBA)

10	AntibodiesIBA 11/2023 - 06/2011
10	Antiphospholipid AntibodiesIBA 11/2023 - 06/2011
9	Biomarkers (Surrogate Marker)IBA 03/2024 - 02/2019
5	Serum Amyloid A Protein (Serum Amyloid A)IBA 10/2022 - 01/2018
4	Prothrombin (Factor II)IBA 12/2022 - 06/2011
4	PhosphatidylserinesIBA 12/2022 - 06/2011
3	VaccinesIBA 12/2022 - 01/2019
3	AutoantibodiesIBA 12/2022 - 01/2020
3	Immunoglobulin A (IgA)IBA 01/2022 - 02/2019
3	MicroRNAs (MicroRNA)IBA 06/2021 - 01/2019
3	Lupus Coagulation Inhibitor (Lupus Anticoagulant)IBA 02/2019 - 06/2011
2	Glycoproteins (Glycoprotein)IBA 12/2022 - 01/2013
2	BNT162 VaccineIBA 12/2022 - 01/2022
2	Rheumatoid FactorIBA 01/2022 - 01/2022
2	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2018
2	GlucocorticoidsIBA 01/2021 - 01/2020
2	Cardiolipins (Cardiolipin)IBA 02/2019 - 01/2013
2	Immunoglobulin G (IgG)IBA 02/2019 - 01/2013
2	Immunoglobulin M (IgM)IBA 02/2019 - 01/2013
1	CryoglobulinsIBA 11/2023
1	AnticoagulantsIBA 11/2023
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 10/2023
1	AntioxidantsIBA 07/2023
1	Pulmonary Surfactant-Associated Protein D (Surfactant Protein D)IBA 06/2023
1	mRNA VaccinesIBA 12/2022
1	ChlorhexidineIBA 10/2022
1	Interleukin-6 (Interleukin 6)IBA 10/2022
1	IntegrinsIBA 09/2022
1	L-SelectinIBA 02/2022
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 02/2022
1	Immunosuppressive Agents (Immunosuppressants)IBA 02/2022
1	Amyloid (Amyloid Fibrils)IBA 01/2022
1	Peptides (Polypeptides)IBA 01/2022
1	Messenger RNA (mRNA)IBA 06/2021
1	AdiponectinIBA 04/2021
1	Leflunomide (Arava)FDA LinkGeneric 01/2021
1	CytokinesIBA 01/2020
1	Infliximab (Remicade)FDA Link 12/2019
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2019
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 08/2019
1	Tetanus Toxoid (Vaccine, Tetanus)FDA Link 01/2019
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 01/2019
1	E-SelectinIBA 01/2019
1	Matrix Metalloproteinases (MMPs)IBA 01/2019
1	Mitochondrial DNA (mtDNA)IBA 12/2017
1	Adalimumab (Humira)FDA Link 01/2017
1	SurvivinIBA 01/2016
1	AutoantigensIBA 12/2011

Therapy/Procedure

2	Therapeutics 01/2021 - 01/2020